Evaluating the diagnostic role of in‐bore magnetic resonance imaging guided prostate biopsy: a single‐centre study-Reference-Cited by-同舟云学术

Evaluating the diagnostic role of in‐bore magnetic resonance imaging guided prostate biopsy: a single‐centre study

Published:2022-04-28 Issue:6 Volume:92 Page:1486-1491
ISSN:1445-1433
Container-title:ANZ Journal of Surgery
language:en
Short-container-title:ANZ Journal of Surgery

Author:

Furrer Marc A.¹²,Hong Anne¹^ORCID,Wetherell David¹,Heinze Stefan B.³,Simkin Paul³,Chow Ken¹⁴⁵^ORCID,Lawrentschuk Nathan¹⁴,Zargar Homayoun¹⁴

Affiliation:

1. Department of Urology Royal Melbourne Hospital Melbourne Victoria Australia

2. Department of Urology, Inselspital, Bern University Hospital University of Bern Bern Switzerland

3. Department of Radiology Royal Melbourne Hospital Melbourne Victoria Australia

4. Department of Surgery University of Melbourne Melbourne Victoria Australia

5. Department of Urology Western Health Melbourne Victoria Australia

Publisher

Wiley

Subject

General Medicine,Surgery

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ans.17713

Reference40 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study

3. Risk Profiles and Treatment Patterns Among Men Diagnosed as Having Prostate Cancer and a Prostate-Specific Antigen Level Below 4.0 ng/mL

4. Adoption of Prebiopsy Magnetic Resonance Imaging for Men Undergoing Prostate Biopsy in the United States

5. European Association of Urology.Prostate Cancer: diagnostic evaluation. Edition 2020. [Cited 22 Jan 2020]. Available from URL:https://uroweb.org/guideline/prostate-cancer/